NCOA4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.64710023398129E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.76999550969026E-11 |
Normal-vs-Stage2 |
2.769800E-04 |
Normal-vs-Stage3 |
9.239800E-04 |
Normal-vs-Stage4 |
5.67069999957148E-07 |
Stage1-vs-Stage2 |
2.807000E-01 |
Stage1-vs-Stage3 |
4.041000E-01 |
Stage1-vs-Stage4 |
3.519200E-01 |
Stage2-vs-Stage3 |
8.114200E-01 |
Stage2-vs-Stage4 |
1.003240E-01 |
Stage3-vs-Stage4 |
2.389200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.3793966796859E-11 |
Normal-vs-AfricanAmerican |
1.65249999994899E-06 |
Normal-vs-Asian |
6.238800E-01 |
Caucasian-vs-AfricanAmerican |
1.900620E-01 |
Caucasian-vs-Asian |
3.709600E-01 |
AfricanAmerican-vs-Asian |
3.030600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.21830340155316E-11 |
Normal-vs-Female |
1.50368999999317E-05 |
Male-vs-Female |
8.799700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
3.22540000263771E-08 |
Normal-vs-Extreme_Weight |
4.13613587824102E-12 |
Normal-vs-Obese |
1.59069999999817E-05 |
Normal-vs-Extreme_Obese |
1.125530E-02 |
Normal_Weight-vs-Extreme_Weight |
6.447400E-01 |
Normal_Weight-vs-Obese |
1.778030E-01 |
Normal_Weight-vs-Extreme_Obese |
6.425200E-01 |
Extreme_Weight-vs-Obese |
2.877600E-02 |
Extreme_Weight-vs-Extreme_Obese |
3.565600E-01 |
Obese-vs-Extreme_Obese |
7.296600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.49610000002676E-06 |
Normal-vs-Age(41-60Yrs) |
4.10599999556283E-08 |
Normal-vs-Age(61-80Yrs) |
2.50389708966736E-11 |
Normal-vs-Age(81-100Yrs) |
1.29979999996532E-06 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.401200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.501000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.316200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.170360E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.024000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.715800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
1.49159573581414E-11 |
Normal-VS-Type2 PRCC |
2.040000E-04 |
Normal-VS-KIRP CIMP |
5.97450000583422E-09 |
Normal-VS-Unclassified PRCC |
3.502000E-03 |
Type1 PRCC-VS-Type2 PRCC |
3.406100E-02 |
Type1 PRCC-VS-KIRP CIMP |
8.989600E-02 |
Type1 PRCC-VS-Unclassified PRCC |
1.186600E-01 |
Type2 PRCC-VS-KIRP CIMP |
1.322610E-03 |
Type2 PRCC-VS-Unclassified PRCC |
9.806400E-01 |
KIRP CIMP-VS-Unclassified PRCC |
4.075400E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
4.46239999951636E-07 |
Normal-vs-N1 |
8.618800E-04 |
Normal-vs-N2 |
3.46439999998616E-06 |
N0-vs-N1 |
8.241200E-01 |
N0-vs-N2 |
2.140800E-01 |
N1-vs-N2 |
2.083200E-01 |
|
|